-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Armata Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2015 to Q3 2024.
- Armata Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
- Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2018 was -$328K, a 74.8% increase from 2017.
- Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2017 was -$1.3M, a 134% decline from 2016.
- Armata Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2016 was -$556K, a 662% decline from 2015.
Income Tax Expense (Benefit), Quarterly (USD)